FAQ

Frequently Asked Questions

Explore the i-Cubed™ FAQs to learn more about our services, processes, and how we can collaborate to drive innovation forward.

Is i-Cubed part of Duke?

i-Cubed™ was established in 2024 and sits within the Duke Clinical Research Institute (DCRI). The DCRI, part of the Duke University School of Medicine, is the world’s largest academic clinical research organization. As an extension of the DCRI, i-Cubed has access to world-renowned leaders in clinical research who have deep expertise in operationalizing global studies. We also partner with colleagues across Duke, like the Office of External Partnerships and the Office for Translation and Commercialization (OTC), to ensure you have access to every opportunity for success. Our team is here to guide you along the way.  

How is i-Cubed governed? 
Who can submit an idea to i-Cubed?

We welcome collaboration with anyone within the DCRI or Duke community who has an innovative idea to improve clinical research. 

As an innovator, what can I expect from i-Cubed? 
As an innovator, what will i-Cubed expect from me?
As an innovator, how will my materials and IP be protected?
Does Duke make money from my innovation? 
Will i-Cubed invest in my idea or startup?  
Will you help me source capital – e.g. external investment or grants?  
Who can I contact with questions about the Startup Innovations pathway?
What partnership services do you provide?

We are flexible and open to a variety of arrangements, such as providing physical or virtual spaces to validate your idea or tool, testing your product using real-world data, receiving feedback from potential users or buyers of your product, or integration into a clinical trial. All of our partnership agreements provide consultation from world-renowned experts at Duke and DCRI. 

What does a partnership with i-Cubed look like?
Who can I contact with questions about the Partner Innovations pathway?